Brief: Verrica's Skin Infection Drug Receives New Chemical Entity Status, Orange Book Listing From US FDA

Verrica Pharmaceuticals

26/03/2024 12:29

March 26 (Reuters) - Verrica Pharmaceuticals Inc
 VRCA.O :
    * VERRICA PHARMACEUTICALS ANNOUNCES THAT YCANTH™ RECEIVES
NEW
CHEMICAL ENTITY STATUS AND ORANGE BOOK LISTING FROM THE FDA
    * VERRICA PHARMACEUTICALS INC - NCE STATUS PROVIDES A
MINIMUM OF
FIVE YEARS OF REGULATORY EXCLUSIVITY

Source text for Eikon:  ID:nGNX2YQ9H7 
Further company coverage:  VRCA.O 

 ((Reuters.Briefs@thomsonreuters.com;))